GSK3B and cancer: Recently, several important studies have highlighted that NUAK1, as a key component of the antioxidant response pathway, is associated with aggressive disease and poor outcome in cancer patients through suppressing Gsk3β-dependent inhibition of NRF2 nuclear localization11,12.